๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

In-vitro/In-vivocomparison of leuprolide acetate release from an in-situ forming plga system

โœ Scribed by Mashayekhi, Roya; Mobedi, Hamid; Najafi, Jamal; Enayati, Marjan

Book ID
121630051
Publisher
Springer (Biomed Central Ltd.)
Year
2013
Tongue
English
Weight
514 KB
Volume
21
Category
Article
ISSN
1560-8115

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Sucrose acetate isobutyrate as an In Sit
Sucrose acetate isobutyrate as an In Situ forming system for sustained risperidone release
โœ Yaxin Lu; Yeling Yu; Xing Tang ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 238 KB

The objective of this study was to develop sustained-release sucrose acetate isobutyrate (SAIB) in situ formulations of risperidone for parenteral delivery. The formulations contained SAIB, solvent (anhydrous ethanol, ethyl lactate, or N-methyl-2-pyrrolidone), and additives such as polylactic acid (

Sustained suppression of pituitary-gonad
Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate
โœ Harish B. Ravivarapu; Katie L. Moyer; Richard L. Dunn ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

The objective of these studies was to develop a leuprolide acetate depot based on an in situ forming drug delivery system (Atrigel(R)) to suppress the pituitary-gonadal axis and in turn the serum testosterone to chemical castration levels for a period of at least 3 months. Formulations with biodegra